A: 25-28 Flashcards
Benzo’s MOA
Bind GABA-A receptor (BZ-binding site) > facilitate Cl- channel opening & increases frequency
- membrane hyperpolarization
Benzos and DOA
super MaN is super fast
DC movies are super long
A is in the middle of mAn
T1/2= 2-40 hrs
Midazolam (oral, I.V) , Nitrazepam (oral)
Alprazolam (oral)
Diazepam (oral, IV) , Clonazepam (oral)
- metabolism: hepatic conjugation
Benzo’s indication
- Status epilepticus (diazepam)
- skeletal m. relaxation ( diazepam)
- absence and myoclonic seizure, infantile spasms (clonazepam)
- bipolar disorder (clonazepam)
- acute anxiety attack
- panic attack
- generalised anxiety disorder
- Sleep problems
Not for major depression
Diazepam indicationns
- Inducation of Anesthetia (IV)
- Preoperative Sedation
- treatment muscle spasticity : centrally acting skeletal Muscle relaxant
- Anxiety, Panic and phobic disorders
- Withdrawal state (ethanol, other sedative hypnotics) - because longer acting benzo
- status epilepticus
Clonazepam indic.
- Anxiety, panic & phobic disorders
- Bipolar
- Seizures
oral!
Benzo’s drug interaction
Antihistamines gen 1
Alcohol
Barb’s
- Additive CNS dep occurs when sedative hypnotic are used with other drugs in the class
- 1st gen antihistamine
- Anti-pscychotics
- opioid analgesics
- tri-cyclic antidepressant
- Barbiturate
- alcohol
Alprazolam indications
oral
- Anxiety, panic and phobic disorders
Nitrazepam indication
Nitra = NIGHT
oral
- Sleep disorders
- insomnia
Midazolam indication
oral, I.V
- preoperative sedation
- Anasthesia (iv)
Toxicities of benzos
- Extension of CNS deppressant action
- tolerance
- dependence liability
Benzo’s antag.
Flumazenil (antagonist at BZ-specific binding site on GABA-A r)
-مازن-
also for zolpidem ocerdose
Non Benzo’s
Zaleplon, Zolpidem- (newer hypnotics) GABA-A agonist
- binds to GABA-A receptor site
- facilitates chloride chn opening and increase duration
Your BMR is up when you sleep well
Busiprone- 5HT partial agonist & possible D2-r Busi is prone to allergies
Melatonin-
Rameltone- Melatonine-r agonist.( activates MT1 & MT2 receptors in supra-chiasmatic nucleus) ram sleeps and dream on Elton
+ SSRI (selective serotonin reuptake inhibitors) : Fluoxetine , (ES) citalopram, Sertraline
flumazenil
administration, duration
toxicities
- I.V
- short T1/2
- SE
- Agitation
- confusion
- possible withdrawal syndrome
- seizures
Zaleplon,
Zolpidem
indication, administration, pharmacokinetics
- Sleep disorders esp when sleep onset is delayed
- oral
- P450 substrate
- Short T1/2
- additive CNS depression with ethanol and other CNS depressants
Zaleplon, zolpidem toxicities
- Extension of CNS depressant effects
- dependence liability ( less than that of benzos because withdrawal symtpms are minimal after sudden discontinuation
Ramelteon mechanism and indication
Activation MT1 & MT2 receptors in suprachiasmatic nucleus (melatonin-r agonsit)
- Sleep disorders esp when onset of sleep is delayed ( same as zaleplon , zolpidem)
- NOT a controlled substance
Ramelteon administration, metabolism , toxicities
- oral
- forms active metabolite via CYP1A2
- Fluvoxamine inhibits metabolism
- SE:
- dizziness
- fatigue
- endrocrine changes
which drug is used in generalized anxiety states
Buspirone ( partial 5-HT agonsit, possibly D2-r)